AI Creates 16 Functional Viruses Targeting E. coli
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Stanford University and the Arc Institute used AI models Evo 1 and Evo 2 — trained on millions of genomes across all domains of life — to generate thousands of novel bacteriophage genomes guided by the architecture of the Phi X-174 virus, which infects E. coli.
- Of the 300 AI-designed genomes synthesized molecule by molecule in the lab and introduced into E. coli, only 16 produced fully functional bacteriophages featuring previously unpublished sequences, different genes, new regulatory elements, and varying genome sizes.
- The AI-generated phages rapidly overcame E. coli strains already resistant to Phi X-174 — a result the authors describe as 'a path toward artificial intelligence–generated phage therapies against rapidly evolving bacterial pathogens.'
- The research, published this week in the journal Science, differs from prior virus-synthesis work because the AI was instructed to design new genomes rather than replicate existing pathogens, producing bacteriophages whose specific DNA sequences diverged considerably from natural ones.
- Moritz Hanke of the Johns Hopkins Center for Health Security told The New York Times there is 'a huge disconnect' between the speed of AI advancement and the development of effective safeguards against misuse for lethal virus creation.
- A Rand Corporation study from roughly three years ago warned that advanced AI systems could refine the planning of biological weapons attacks — a concern the nonprofit said has grown as AI capabilities have expanded faster than regulatory oversight.
Why it matters: Antibiotic resistance is a documented growing problem, and the study's 16 AI-designed phages successfully infected E. coli already resistant to the reference virus — establishing a concrete foundation for personalized phage therapies that could evolve alongside bacterial pathogens instead of relying on fixed antibiotics.
Ask SkimNews
